Targeting high-grade B cell lymphoma with CD19-specific T cells.
Lehmann FM, Maurberger A, Feicht S, Helm F, Ladinig C, Kieback E, Uckert W, Kammertöns T, Kremmer E, Mautner J, Gerbitz A, Bornkamm GW.
Lehmann FM, et al. Among authors: uckert w.
Int J Cancer. 2014 Sep 1;135(5):1153-64. doi: 10.1002/ijc.28760. Epub 2014 Feb 20.
Int J Cancer. 2014.
PMID: 24500882